Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGP345A in Opioid-Induced Constipation
NCT05133076Phase 2Completed
- Sponsor
- BioGaia AB
- Start
- Jan 2022
- Primary completion
- Dec 2024
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus gasseri DSM 27123 in opioid-induced constipation (OIC), sponsored by BioGaia AB. Started Jan 2022; status: completed.
02
Drugs
lactobacillus gasseri DSM 27123
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT05133076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05133076.